Mediator complex subunit 1 (Med1)/Thyroid hormone receptor-associated protein 220 (TRAP220), an essential component of thyroid hormone receptor-associated proteins (TRAP)/mediator, plays important roles in hormone responses and tumorigenesis. However, the role of Med1 in the DNA damage response has not been studied. In this study, we found that DNA damage, resulted from γ-irradiation, ultraviolet (UV)-irradiation, or hydroxyurea, induced phosphorylation of Med1 in vivo. Phosphorylation of Med1 was abrogated by either caffeine or wortmannin treatment, suggesting that Med1 is phosphorylated through the DNA damage checkpoint pathway. A checkpoint kinase 1 (Chk1)/checkpoint kinase 2 (Chk2) consensus phosphorylation motif was identified at Serine 671 of Med1 and Ser671 motif was primarily phosphorylated by Chk2 in vitro. Moreover, the in vivo phosphorylation of Med1 was abrogated by a Chk2 inhibitor, and physical interaction between Chk2 and Med1 was observed, confirming that Chk2 is responsible for Med1 phosphorylation upon DNA damage. These results suggest that Med1 is a novel target for the DNA damage checkpoint pathway and may participate in the DNA damage response. Consistent with this notion, knockdown of Med1 expression caused a significant increase in cellular sensitivity to UV irradiation. Moreover, microarray analysis revealed that the UV-induced activation of the transcription of important regulators of cell cycle control and DNA repair, including p21, Gadd45, Rad50, DnaJ, and RecQL, was impaired upon Med1 knockdown. Taken together, our data suggest that Med1 is a novel target for Chk2-mediated phosphorylation and may play a role in cellular DNA damage responses by mediating proper induction of gene transcription upon DNA damage.
Introduction
The eukaryotic DNA damage checkpoint, which is activated in response to DNA damage, ensures genomic integrity and suppresses tumorigenesis by regulating various cellular responses, including cell cycle arrest and DNA repair [1, 2] . The coordinated regulation of the expression of a subset of genes that play important roles in these processes is an essential step in proper DNA damage responses. Failure to induce the expression of these genes often causes incomplete DNA damage repair, thereby resulting in genomic instability [2, 3] . The checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) checkpoint kinases are activated by the upstream kinases ataxia-telangiectasia mutated (ATM) and ATM and RAD3-related (ATR) upon DNA damage and play a central role in the DNA damage response by regulating target protein functions through phosphorylation [4, 5] . Many regulatory proteins have been revealed as substrates of the DNA damage checkpoint pathway, most of which are either tumor suppressors or are closely related to cancer [6] . Thus, the identification of physiological targets and exploration of their role in DNA damage responses are critical issues.
Med1 (also known as TRAP220/PBP/DRIP205/CRSP1/RB18A) is a central component of the TRAP/mediator complex that acts as a molecular bridge between RNA polymerase and various transcription activators [7, 8] . In addition to its essential role in transcription activation mediated by many hormone receptors, such as the estrogen receptor (ER), the thyroid receptor (TR), and the androgen receptor (AR), previous studies have shown that Med1 is associated with human cancers. While overexpression of Med1 has been observed in breast and prostate cancers [9, 10] , downregulation of Med1 has been reported in melanoma [11] . It has been suggested that increased Med1 levels mainly contribute to tumorigenesis through the roles of Med1 in the cell cycle and cell proliferation. Our group has previously shown that loss of Med1 expression is strongly associated with lung cancer progression and poor survival of lung cancer patients [12, 13] . Moreover, we revealed that reduced Med1 expression is associated with increased invasion and metastasis of lung cancer cells. These results suggest that Med1 is involved in tumorigenesis and cancer progression through its pleotropic functions in various cellular processes. However, whether Med1 is involved in DNA damage responses has not yet been determined.
Here, we observed that Med1 is a novel target of the DNA damage checkpoint pathway. We observed that Med1 is phosphorylated in vivo upon exposure to various inducers of DNA damage, such as ionizing radiation (IR) and ultraviolet (UV) irradiation. In addition, we revealed a Chk1/Chk2 consensus phosphorylation motif located at Ser671 that is directly phosphorylated by Chk2 using in vitro kinase assays. Moreover, knockdown of Med1 increased cellular sensitivity to UV irradiation and abrogated the DNA damageinduced transcription of many important regulators, including p21, Gadd45, Rad50, DnaJ, and RecQL.
Materials and Methods

Cell culture and treatment
HEK293 and MCF7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS (Gibco, Waltham, USA). For genotoxic treatment, the cells were treated with γ-irradiation (IR) (5 Gy) using a 131 Cs source, UV (10 J/m 2 ) using a germicidal UV lamp and a UV radiometer (UVX-25, UltraViolet Products Ltd, Upland, USA), or hydroxyurea (HU, 1.5 mM) (Sigma-Aldrich Co., St Louis, USA). Caffeine was purchased from Sigma-Aldrich, and wortmannin was obtained from Calbiochem (San Diego, USA).
Western blot analysis and λ phosphatase treatment
Cells were lysed in IPH lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, and 0.1 mM PMSF). For protein phosphatase treatment, the clarified lysates were incubated with 2000 units of λ phosphatase (New England BioLabs Inc., Ipswich, USA) for 2 h at 30°C. To inhibit λ phosphatase activity, a mixture of phosphatase inhibitors (10 mM NaF, 10 mM Na 4 P 2 O 7 , 5 mM NaVO 3 , and 10 mM β-glycerophosphate) was added.
To analyze Med1 band shifts, cell lysates were separated in 6% (wt/vol) SDS-PAGE gels (37.5:1 ratio of acrylamide to bisacrylamide). The gels were run for 16 h at 20 mA to maximize the mobility shift.
For other western blot analysis, cell lysates were separated in standard SDS-PAGE gels (29:1 ratio of acrylamide to bis-acrylamide). Western blot analysis was performed using an anti-Med1 antibody (Santa Cruz Biotech, Santa Cruz, USA). Actin protein expression was also monitored using an anti-actin antibody (Sigma) as an internal loading control. Detection of the western blots was performed using the Amersham ECL detection system (GE Healthcare, Pittsburgh, USA), and images were obtained with BioMax X-ray film (SigmaAldrich). The experiments were repeated at least three times, and representative data are shown [12] .
In vivo phosphorylation analysis
Cells were washed twice with TBS (15 mM Tris-HCl, pH 7.5, and 125 mM NaCl), followed by 4 h of labeling in 3 ml of phosphatefree Dulbecco's modified Eagle's medium/10% dialyzed fetal bovine serum containing 0. phosphate. The labeled cells were treated with 1 ml of Nonidet P-40 lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, 0.5% Nonidet P-40, 50 mM NaF, 10 μM Na 3 VO 4 , 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, and 0.1 mM phenylmethylsulfonyl fluoride) and centrifuged to produce clear lysates.
The labeled lysates were immunoprecipitated with the anti-Med1 antibody and protein A-agarose (Roche, Indianapolis, USA). After rigorous wash, the samples were boiled and loaded on SDSpolyacrylamide gels for electrophoretic separation. Phosphorylated protein species were visualized through autoradiography using BioMax X-ray film.
Construction of plasmids and GST fusion protein production
To generate expression plasmids for glutathione S-transferase (GST) fused to a peptide containing the Ser671 motif of Med1, complementary oligonucleotides encoding 13 amino acids flanking the Ser671 motif of Med1 (663-SSPLERQNSSSGS-675) were synthesized and subcloned into the EcoRI/XhoI sites of the pGEX-5X vector (Amersham Pharmacia Biotech, Piscataway, USA). To generate a GST-fusion protein containing 200 amino acids of Med1, the region of Med1 spanning amino acids 571-770 was PCR amplified from the Med1 expression plasmid (pWZL hygro Flag HA-TRAP220, Addgene plasmid #17433, Addgene, Cambridge, USA) using the following PCR primers: Forward 5′-ATCCCGGAATTCCCCATT ACCACCTTGTTT-3′, Reverse 5′-CTCGAGTCGACCGGATAGT CGGACCATCCT-3′, where the underlined bases are sites for EcoRI and SalI, respectively. The amplified PCR fragment was digested with EcoRI/SalI and subcloned into the EcoRI/SalI sites of the pGEX-5X vector. The S671A mutation in GST-Med1 (amino acids 571-770) was generated using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, USA) and the following primer: 5′-TTAGAAAGGCAGAACGCCTCTTCCGGATCCCCCC GCATGGAAATA-3′. The mutation was verified by sequencing. GST-fusion proteins were expressed in Escherichia coli BL21 (DE3) cells after induction with isopropyl-1-thio-β-D-galactopyranoside (IPTG) and purified from cleared cellular lysates through affinity chromatography using glutathione-Sepharose beads (Amersham Pharmacia Biotech, Cambridge, England).
In vitro kinase assay
In vitro kinase assays for Chk1 and Chk2 were performed as previously described [14] . Briefly, 0.1 μg of recombinant GST-Chk2 or GST-Chk1 (Upstate Biotechnology, Lake Placid, USA) and 2 μg of purified GST-fusion protein substrates were incubated in a reaction buffer containing 10 mM HEPES (pH 7.5), 50 mM KCl, 10 mM MgCl 2 , 0.5 mM EDTA, 1 mM dithiothreitol, 50 μM ATP and 5 μCi of [γ-
32 P]ATP. The mixture was incubated at 30°C for 30 min and electrophoresed in a denaturing polyacrylamide gel. The gel was stained with coomassie blue to visualize the substrates and then dried, and the phosphorylated proteins were detected through autoradiography using BioMax X-ray film. The experiments were repeated at least three times, and representative data are shown.
GST pull-down assay
GST pull-down assays were performed as previously described [15] . Briefly, HEK293 cells were prepared using Nonidet P-40 lysis buffer. The cell lysates were then precleared through incubation with glutathione-Sepharose 4B beads for 1 h at 4°C. Next, the precleared lysates were added to 2 μg of either the GST or the GST-Chk2 protein immobilized on glutathione-Sepharose 4B beads and incubated, followed by incubation for 3 h at 4°C. After five times wash with Nonidet P-40 lysis buffer, the bound protein was eluted and analyzed by western blot analysis using the anti-Med1 antibody.
Generation of Med1-silenced cells and cell survival assay
To generate an MCF7 cell line in which Med1 was knocked down, an previously generated expression plasmid containing Med1 shRNA (shMed1) (pU6-shMed1) or a negative control shRNA (NC) [12] was transfected into MCF7 cells using Lipofectin reagent (Invitrogen, Carlsbad, USA), and the cells were selected with 1 μg/ml of puromycin (Sigma) for 2 days. The resulting colonies were pooled for subsequent experiments. Cell survival rate after treatment with UV irradiation (10 J/m 2 ) was measured using a colony-forming assay. Five hundreds cells were seeded on 60-mm dishes and exposed to UV irradiation (10 J/m 2 ). After 2 weeks, the resulting colonies were fixed, stained with 2% methylene blue and counted. The experiments were independently repeated three times, and the data are presented as the mean values with standard deviations.
Microarray analysis
Total RNA was isolated from MCF7-shNC and MCF7-shMed1 cells using the RNeasy Micro Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The gene expression profiles of each sample were analyzed using Affymetrix U133 Plus 2.0 microarrays (Affymetrix, Santa Clara, USA), and the genes whose expression differed by a factor of at least 2 in MCF7-shMed1 cells relative to MCF7-shNC control cells were selected for further analysis.
Results
Med1 is phosphorylated upon DNA damage
Med1/TRAP220 has been implicated in various cancers [9] [10] [11] [12] [13] 16] , but whether Med1 is involved in the DNA damage response has not yet been determined. The DNA damage checkpoint controls various cellular processes upon DNA damage mainly through the phosphorylation of downstream targets [2, 5] . To investigate whether Med1 is a possible target for the DNA damage checkpoint, we first examined whether Med1 is phosphorylated upon DNA damage. To this end, HEK293 cells were exposed to various DNA-damaging agents, such as IR, UV, and HU, and Med1 expression was examined by western blot analysis. Interestingly, we observed the appearance of a less rapidly migrating form of Med1 upon DNA damage, as shown in Fig. 1A , which implied that Med1 may be phosphorylated. Further, it was also found that the DNA damage-induced mobility shift of Med1 was abolished by λ-phosphatase (λ-PPase) treatment, suggesting that Med1 is phosphorylated in response to DNA damage (Fig. 1B) . Inhibition of this Med1 band shift by λ-phosphatase was reversed by λ-phosphatase inhibitors, confirming the effect of λ-phosphatase (Fig. 1B) . Because some experimental results appeared to indicate a reduction of the amount of the Med1 protein after DNA damage or λ-phosphatase treatment, we examined the changes in the amount of the Med1 protein after the DNA damage signal. However, western blot analysis revealed that Med1 protein levels remained unchanged up to 24 h after DNA damage ( Supplementary Fig. S1 ). To further confirm the DNA damage-induced phosphorylation of Med1, we next examined the in vivo phosphorylation of Med1 upon IR and UV treatment using [
32 P]orthophosphate labeling in HEK293 cells. As shown in Fig. 1C , both IR and UV treatment induced strong phosphorylation of Med1, while the Med1 protein levels were not changed, indicating that DNA damage induces Med1 phosphorylation. To examine whether Med1 phosphorylation is mediated by the DNA damage checkpoint, we next treated the cells with caffeine or wortmannin, both of which are potent inhibitors of the ATR/ATM-Chk1/Chk2 pathway. Co-treatment with caffeine or wortmannin successfully inhibited the DNA damage-induced phosphorylation of Med1 in vivo (Fig. 1D) . These results confirm that Med1 is phosphorylated upon DNA damage through the DNA damage checkpoint pathway.
Med1 is phosphorylated at Ser671 by Chk2 kinase in vitro
To identify the site of Med1 phosphorylation upon DNA damage, we performed amino acid sequence analysis of Med1. Interestingly, a LxRxxS Chk1/Chk2 consensus phosphorylation motif [14] at 666-LERQNS-671, located near the LxxLL nuclear receptor ligand-binding domain was observed (Fig. 2A) . This Chk1/Chk2 consensus phosphorylation motif is well conserved across various mammalian species (Fig. 2B) , suggesting a potential role of this motif in Med1 function.
To test whether the putative target site in Med1 is phosphorylated by Chk1 and Chk2, we generated a GST-fusion protein containing 13 amino acids (from 571Pro to 770Ser) spanning the Med1 Ser671 motif and performed Chk1/Chk2 in vitro kinase assays. GST-fusion proteins containing the Ser216 motif of Cdc25C or the Ser988 motif of Brca1 were used as positive controls. Consistent with a previous report [17] , the Ser216 motif of Cdc25C was primarily phosphorylated by Chk1, while the Ser988 motif of Brca1 was more strongly phosphorylated by Chk1 (Fig. 2C) . Interestingly, the Ser671 motif of Med1 was not strongly phosphorylated by Chk1. However, the Ser671 motif of Med1 was strongly phosphorylated by Chk2 to the same extent as the Ser988 motif of Brca1 (Fig. 2C) , suggesting that the Ser671 motif of Med1 is a good substrate for Chk2.
To avoid possible artifacts due to using short target motifs as kinase substrates, we next examined the phosphorylation of a larger fragment of Med1 by Chk1 and Chk2. A 200-amino acid fragment of Med1 containing the Ser671 motif (from 571Pro to 770Ser) was generated as a GST-fusion protein and used as the substrate for The phosphorylation of a GST fusion protein containing the Ser671 motif of Med1 (amino acids 571-770) was examined using in vitro Chk1 and Chk2 kinase assays. GST-fusion proteins containing the Ser988 motif of Brca1 and the Ser216 motif of Cdc25C were used as positive controls. After SDS-PAGE-mediated separation of the reaction mixture, the gel was stained with coomassie blue to visualize the GST proteins (upper panel) and the phosphorylated signal was obtained through autoradiography (lower panel). (D) After SDS-PAGE-mediated separation of the reaction mixture, the gel was stained with coomassie blue to visualize the GST proteins (upper panel), and the phosphorylation signal was determined through autoradiography (lower panel). The full-length GST-Med1 protein (amino acids 571-770) (*) and the 40 KDa cleaved fragment (#) were indicated. The wild-type and S671A mutant GSTMed1 (GST-Med1 S/A) fragments were used as substrates for the in vitro Chk2 kinase assay. (E) Wild-type and S671A mutant GST-Med1 (GST-Med1 S/A) fragments were used as substrates for the in vitro Chk2 kinase assay. After SDS-PAGE-mediated separation of the reaction mixture, the gel was stained with coomassie blue to visualize the GST proteins (upper panel), and the phosphorylation signal was determined through autoradiography (lower panel). The full-length GST-Med1 protein (amino acid 571-770) (*) and the 40 KDa cleaved fragment (#) were indicated. in vitro kinase assays. As shown by the results of coomassie staining presented in Fig. 2D , the purified GST-Med1 substrate appeared as a mixture of several fragments, including the full-length GST-Med1 sequence of~50 kDa (amino acids 571-770) (indicated with *) and an~40 kDa cleaved fragment (indicated with #). Based on its size, the 40 kDa GST-Med1 fragment was assumed to contain the Ser671 motif at its C-terminal. Therefore, if the Ser671 motif is the target site of Chk2, it is expected that both the 50 kDa full-length GSTMed1 sequence and the 40 kDa cleaved GST-Med1 fragment will be phosphorylated. As expected, both GST-Med1 proteins were strongly phosphorylated by Chk2, while their phosphorylation by Chk1 was much weaker (Fig. 2D) . To verify whether Ser671 of Med1 is the target site of Chk2-mediated phosphorylation, we substituted Ala for Ser671 in the 200-amino acid GST-Med1 (amino acids 571-770) fusion protein using site-directed mutagenesis and examined its phosphorylation by Chk2. The in vitro Chk2 kinase assay using wild-type and Ser671Ala (S/A) Med1 revealed that mutation of Ser671 completely abolished phosphorylation by Chk2 (Fig. 2E) . These results suggest that the Ser671 motif of Med1 is a specific target site for Chk2-mediated phosphorylation.
Chk2 phosphorylates and physically associates with Med1
To further confirm the Chk1-dependent phosphorylation of Med1, we examined the effect of a Chk2-specific chemical inhibitor on the DNA damage-induced in vivo phosphorylation of Med1. As shown in Fig. 3A , pretreatment with the Chk2 inhibitor (Chk2 inhibitor II) efficiently suppressed Med1 phosphorylation in vivo upon UV irradiation. These results indicate that Chk2 activity is responsible for Med1 phosphorylation in response to DNA damage.
Based on the Chk2-dependent phosphorylation of Med1, we further examined whether Chk1 physically associates with Med1. The bacterially produced GST-Chk2 protein was mixed with HEK293 lysates in GST pull-down assays, and endogenous Med1 protein was found to bind with GST-Chk2 but not the GST control (Fig. 3B) . These results suggest that Chk2 proteins physically associate with and phosphorylate Med1 in response to DNA damage.
Med1 is required for the DNA damage response
In vivo phosphorylation of Med1 in response to DNA damage and Chk2-dependent phosphorylation of the S671 motif of Med1 in vitro suggest that Med1 may play a role in the proper cellular response to DNA damage. To explore the role of Med1 in the DNA damage response, we examined whether depletion of Med1 affects cellular sensitivity to DNA damage. To deplete endogenous Med1 expression, we generated an RNAi plasmid expressing short hairpin RNA (shRNA) targeting the 3'-untranslated region (UTR) of the Med1 gene under the control of the U6 promoter. Western blot analysis showed that the Med1 shRNA-containing plasmid successfully suppressed Med1 expression in MCF7 cells, while the control RNAi plasmid, expressing negative control shRNA, did not affect the Med1 levels (Fig. 4A) . Cell survival after treatment with UV irradiation (10 J/m 2 ) was measured by MTT assay. As shown in Fig. 4B , Med1 knockdown did not change the cell survival rate from the basal levels; however, cell survival upon UV irradiation was dramatically decreased upon Med1 knockdown, while negative control shRNA-treated cells showed similar survival to wild-type cells at this UV irradiation dose. These results suggest that Med1 function is critical for proper cellular survival after DNA damage.
DNA damage-induced transcription is essential for a proper cellular response to DNA damage [18] . Because Med1 is a transcription mediator, we explored whether Med1 is involved in the DNA damage response through the modulation of gene expression. To explore the changes in gene expression upon Med1 knockdown, we compared the gene expression profiles of Med1-depleted MCF7 cells and control MCF7 cells (MCF7-shNT) upon UV irradiation (10 J/m 2 ) using Affymetrix oligonucleotide microarrays. While many genes showed expression changes upon Med1 knockdown, we focused on DNA damage response-related genes to identify regulators that mediate the increase in cellular sensitivity to DNA damage upon Med1 knockdown. The gene expression analysis of MCF7-shMed1 cells and control MCF7-shNT cells revealed that upon UV irradiation, Med1 knockdown led to the aberrant induction of many DNA damage response-related genes, including p21, Gadd45, Rad50, DnaJ, and RecQL (Fig. 4C) . These results suggest that Med1 is involved in the DNA damage response by regulating the expression of various DNA damage response-related genes.
Discussion
In this study, we have presented evidences that Med1 is a novel target of the DNA damage checkpoint and that Med1 is phosphorylated upon exposure to various inducers of DNA damage in vivo. The DNA damage-induced phosphorylation of Med1 is mediated by the DNA damage checkpoint pathway. Furthermore, we observed a Chk1/Chk2 consensus phosphorylation motif in Med1 at Ser671, and this motif was primarily phosphorylated by Chk2 in the in vitro kinase assay. Collectively, these results suggest that Med1 may be involved in the DNA damage response. Consistent with this notion, knockdown of Med1 increased cellular sensitivity to UV irradiation. Furthermore, the induction of many important regulators upon DNA damage was abrogated by Med1 knockdown. Thus, these results suggest that Med1 may play a role in the DNA damage response through phosphorylation by the DNA damage checkpoint. Regulation of Med1 function by protein phosphorylation has been reported previously. Pandey et al. [19] reported that ERK phosphorylates Med1 at two threonine residues (Thr1032 and Thr1457) and that this phosphorylation controls the subcellular localization, protein stability and transcriptional coactivation function of Med1. Misra et al. [20] previously identified several PKCand PKA-mediated phosphorylation target sites in Med1 (Ser656, Ser756, Ser796, and Ser1345). These authors also showed that Med1 phosphorylation mediated by the Raf/MEK/MAPK pathway activates the transcriptional coactivator function of Med1. These studies demonstrated that the transcriptional coactivator function of Med1 is activated by protein phosphorylation upon mitogenic stimulation. In addition, it has been shown that phosphorylation by different MAPKs modulates many aspects of Med1 function, such as subcellular localization, protein stability and coactivator functions [19, 20] . These studies suggest that Med1 is precisely controlled by different kinases upon exposure to various stimuli. The results presented in the present study suggest a potential link between the DNA damage checkpoint and Med1. Thus, the present study provides the first evidence that Med1 is phosphorylated upon DNA damage. Moreover, we showed that Med1 is phosphorylated by Chk2 at Ser671 in vitro. These results suggest that the DNA damage checkpoint may control Med1 function through the phosphorylation of a distinct target motif.
How DNA damage-induced phosphorylation affects the function of Med1 is an important question raised by this study. We examined Med1 protein levels after DNA damage, but no significant change was observed ( Supplementary Fig. S1 ), suggesting that DNA damageinduced phosphorylation may not affect the protein stability of Med1. Further elucidation of the role of DNA damage-induced phosphorylation on Med1 function will require additional studies.
We observed that knockdown of Med1 resulted in the defective induction of many DNA damage-related genes upon DNA damage, such as p21, Gadd45, Rad50, DnaJ, and RecQL. These genes have been shown to be directly involved in the DNA damage response. p21 and Gadd45 play crucial roles in mediating cell cycle arrest upon DNA damage [21] [22] [23] [24] . Rad50, DnaJ, and RecQL are critical regulators of DNA damage repair [25] [26] [27] . Cell cycle arrest is an essential cellular response to DNA damage that ensures time for the repair of damaged DNA [6] . The repair of DNA lesions relies on different molecular machinery involving various DNA repair pathways, such as homologous recombination (HR) and nonhomologous end joining (NHEJ) [28] . Abrogation of the proper induction of critical genes in the DNA damage response could thus result in failure of the normal DNA damage response. Consistent with this notion, Med1-deficient MCF7 cells showed decreased survival upon UV irradiation. These results suggest that Med1 function is critical for the proper DNA damage response. Thus, the absence of Med1 might lead to improper DNA damage responses and increase the likelihood of tumorigenesis and tumor progression by increasing genomic instability. Downregulation of Med1 has been observed in metastatic melanoma [11] . We also previously demonstrated that Med1 protein levels were decreased in human lung cancer patients and induced cancer metastasis [12, 13] . Whether this decrease in Med1 expression in cancer specimens is related to its role in the DNA damage response is an interesting question that should be addressed in further studies. In addition, how the DNA damage-induced phosphorylation of Med1 plays a role in modulating gene expression upon DNA damage requires further study. Interestingly, Frade et al. [29, 30] previously reported that RB18A, a member of the TRAP220/Med1 family, inhibits the p21 promoter. However, Robert Roeder's group [31] showed that the association of Med1 with the p21 promoter decreased after DNA damage. Moreover, another group reported that Med1 binding to p21 was increased upon UV irradiation [32] . These contradictory results illustrate the complex nature of the cellular transcription network. The different effects of Med1 on the p21 promoter may be due to different cellular contexts; however, the detail mechanism remains to be determined in future studies.
Taken together, our results indicated that Med1 is phosphorylated upon DNA damage through the DNA damage checkpoint. Although the precise mechanism by which DNA damage-mediated phosphorylation of Med1 controls its transcriptional function remains to be explored, our results suggest that Med1 may play a role in ensuring proper DNA damage responses and in maintaining genomic stability.
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